selank mastery course
Unit 7 of 11
chemistry and pharmacokinetics
Thr-Lys-Pro-Arg-Pro-Gly-Pro -- seven residues, two origins
seven amino acids, carefully arranged
selank's sequence (Thr-Lys-Pro-Arg-Pro-Gly-Pro) combines the first four residues of tuftsin with a stabilizing Pro-Gly-Pro tail. this unit explores the chemistry, structural comparison to tuftsin and semax, and the intranasal pharmacokinetic profile.
selank's chemistry is defined by a deliberate modification: adding Pro-Gly-Pro to tuftsin's C-terminus. this single design choice transformed a rapidly degraded immune peptide into a metabolically stable CNS-active compound.
chemistry at a glance
key molecular and pharmacokinetic parameters.
7 residues
Thr-Lys-Pro-Arg-Pro-Gly-Pro -- the full sequence
751 Da
molecular weight -- small enough for intranasal absorption
intranasal
primary administration route in all clinical formulations
minutes vs hours
tuftsin half-life vs selank -- Pro-Gly-Pro extends stability
interactive explorer
explore the key concepts for this unit.
peptide sequence viewer
key terms
definitions you will encounter throughout this unit.
A
the specific order of amino acids (building blocks of proteins) in a peptide chain. selank's sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, where each three-letter abbreviation represents one amino acid. the sequence determines the peptide's shape, function, and how it interacts with receptors and enzymes.
C
the end of a peptide chain that has a free carboxyl group (-COOH). peptide chains have two ends: the N-terminus (amino end) and C-terminus (carboxyl end). the Pro-Gly-Pro extension was added to tuftsin's C-terminus to create selank. modifications at the C-terminus are a common strategy in peptide drug design to resist enzymatic degradation.
M
how long a molecule resists being broken down by enzymes in the body. tuftsin is rapidly degraded by peptidases (enzymes that cut peptide bonds) within minutes. selank's Pro-Gly-Pro tail shields the tuftsin core from these enzymes, extending its functional half-life from minutes to hours.
I
the fraction of a drug that reaches the bloodstream (and ultimately the brain) when delivered through the nose. for peptides, intranasal delivery can bypass the blood-brain barrier via olfactory nerve pathways. selank's small size (751 Da) and chemical properties make it suitable for nasal absorption.
P
the study of how the body handles a drug over time -- absorption (how it gets in), distribution (where it goes), metabolism (how it's broken down), and excretion (how it leaves). abbreviated ADME. selank's PK profile is characterized by rapid intranasal absorption and moderate metabolic stability conferred by the Pro-Gly-Pro tail.
P
the enzymatic breakdown of proteins and peptides into smaller fragments or individual amino acids. proteolytic enzymes (proteases/peptidases) in the blood and tissues rapidly destroy most peptides, which is why peptide drugs typically have very short half-lives. selank's design specifically addresses this problem.
selank's structure explained -- the simple version
what each part of the seven-amino-acid sequence actually does.
selank is built from seven amino acids (the building blocks of all proteins) arranged in a specific order: Thr-Lys-Pro-Arg-Pro-Gly-Pro. the first four -- threonine, lysine, proline, arginine -- come directly from tuftsin, a natural immune peptide your body already makes. the last three -- proline, glycine, proline -- are an artificial tail added by Russian researchers to make the peptide last longer in the body. each amino acid contributes something specific: lysine and arginine carry positive electrical charges that help the peptide interact with cell receptors (proteins on cell surfaces that detect signals), while the proline residues create rigid kinks in the chain that make it harder for enzymes (proteins that break down other molecules) to cut it apart.
A
each amino acid in selank is connected to the next by an amide bond (also called a peptide bond) -- a chemical link formed when the carboxyl group (-COOH) of one amino acid reacts with the amino group (-NH2) of the next, releasing a water molecule. these bonds are relatively stable but can be cleaved by peptidase enzymes. the backbone of selank's chain adopts a specific three-dimensional shape determined by the rotation angles around each peptide bond. proline is unusual because its side chain loops back and bonds to the backbone nitrogen, locking the bond angle and creating a rigid kink that limits how the chain can fold. this rigidity is a key part of why the Pro-Gly-Pro tail protects the peptide from enzymatic attack.
advanced: why sequence order matters
the Thr-Lys-Pro-Arg order in tuftsin's core is not arbitrary -- it was selected by evolution for immune signaling. the lysine at position 2 and arginine at position 4 are both positively charged at physiological pH (the slightly alkaline conditions inside the body, around pH 7.4), creating a charge pattern that matches binding sites on immune cell receptors. swapping even two residues -- for example, putting arginine at position 2 and lysine at position 4 -- dramatically reduces phagocytosis stimulation (the ability to trigger immune cells to engulf pathogens). this sequence sensitivity is why selank preserves tuftsin's exact order rather than rearranging the same amino acids.
advanced: stability vs activity tradeoff
modifying a peptide to resist degradation can inadvertently change how it interacts with receptors. the Pro-Gly-Pro extension was a successful compromise -- it shields tuftsin's vulnerable C-terminus (the tail end of the peptide chain) from carboxypeptidases (enzymes that clip amino acids from the end) without distorting the tuftsin core's shape enough to lose receptor binding. other stabilization strategies, like replacing natural L-amino acids with their mirror-image D-forms or attaching large polymer chains (PEGylation), can extend half-life even further but often reduce or eliminate the original biological activity. the Pro-Gly-Pro approach preserves tuftsin's immune function while adding entirely new CNS (central nervous system) effects that the original tetrapeptide lacked.
where this has been studied
structural and chemical characterization data -- primarily from Russian and early peptide chemistry literature.
NMR / structural studies
nuclear magnetic resonance (NMR) spectroscopy has been used to characterize selank's three-dimensional conformation in solution. studies show the Pro-Gly-Pro tail adopts a polyproline II helix-like structure, a common motif in collagen and other stable biological proteins. this conformation helps explain the peptide's resistance to enzymatic degradation.
stability assays
in vitro stability testing (experiments in test tubes, not in living organisms) with blood plasma shows selank degrades significantly slower than tuftsin. the Pro-Gly-Pro tail protects against carboxypeptidase cleavage, though selank is still eventually broken down -- it is not permanently stable. the exact half-life varies depending on the species and tissue tested.
metabolite identification
when selank does break down, it produces fragments that have been identified using mass spectrometry (a technique that measures the weight of molecules). the primary metabolite is des-Pro selank, where the terminal proline is clipped off. interestingly, some metabolites retain biological activity, suggesting selank may function as a prodrug (a compound that releases active fragments as it degrades).
structure-activity relationships
systematic modification studies tested dozens of tuftsin analogs with different C-terminal extensions. Pro-Gly-Pro was selected because it provided the best combination of metabolic stability and retained biological activity. other tested extensions -- such as Gly-Gly-Gly or Ala-Ala-Ala -- either failed to improve stability or eliminated the immune and CNS activity.
peptide drug design approaches
how selank's Pro-Gly-Pro strategy compares to other methods for stabilizing peptide therapeutics.
Pro-Gly-Pro extension
- adds 3 natural amino acids to the C-terminus
- proline's rigid ring blocks enzyme access
- preserves parent peptide's receptor binding
- can add new biological activities (CNS effects)
- used in selank and semax -- both clinically approved in Russia
D-amino acid substitution
- replaces natural L-amino acids with mirror-image D-forms
- enzymes cannot recognize the reversed shape
- dramatically extends half-life (hours to days)
- often reduces or eliminates receptor binding
- used in some synthetic hormone analogs
PEGylation
- attaches polyethylene glycol (PEG) polymer chains
- large PEG shield hides peptide from enzymes and kidneys
- extends half-life from hours to days or weeks
- increases molecular weight substantially
- used in pegfilgrastim, peginterferon, and many biologics
cyclization
- connects the peptide's head to its tail, forming a ring
- eliminates free termini that enzymes typically attack
- constrains the shape, which can improve receptor selectivity
- may reduce absorption through biological membranes
- used in cyclosporine, octreotide, and melanotan II
PK data limitations: detailed pharmacokinetic parameters (exact bioavailability, Cmax, AUC) for intranasal selank are not publicly available from peer-reviewed Western journals. most PK characterization comes from Russian pharmaceutical filings.